JPMorgan Chase & Co. lowered shares of Metagenomi (NASDAQ:MGX – Free Report) from an overweight rating to a neutral rating in a report published on Thursday, MarketBeat.com reports. They currently have $6.00 target price on the stock, down from their prior target price of $16.00. A number of other equities research analysts have also issued […]
JPMorgan Chase & Co. cut shares of Metagenomi (NASDAQ:MGX – Free Report) from an overweight rating to a neutral rating in a research report report published on Thursday morning, MarketBeat.com reports. They currently have $6.00 price objective on the stock, down from their previous price objective of $16.00. Several other brokerages also recently commented on […]
Metagenomi, Inc. (NASDAQ:MGX – Get Free Report) has earned an average rating of “Buy” from the six ratings firms that are covering the company, MarketBeat reports. Six research analysts have rated the stock with a buy recommendation. The average twelve-month price target among analysts that have covered the stock in the last year is $21.40. […]
Metagenomi, Inc. (NASDAQ:MGX – Get Free Report) major shareholder Holdings A/S Novo bought 800,000 shares of the company’s stock in a transaction that occurred on Tuesday, February 13th. The shares were bought at an average cost of $15.00 per share, for a total transaction of $12,000,000.00. Following the transaction, the insider now directly owns 1,739,175 […]